Skip to main content
. Author manuscript; available in PMC: 2020 Jan 24.
Published in final edited form as: J Clin Immunol. 2019 Jan 24;39(1):112–117. doi: 10.1007/s10875-019-0589-0

Figure 1. Immunodeficiency-related vaccine-derived rubella virus (iVDRV) clinical features.

Figure 1.

A) Patient 5 with typical granulomatous inflammation. B) Patient 5 demonstrating relentless progression over one year. C) Patient 6 in 2016 after surgical excision. D) Patient 6 after 2.5 months of nitazoxanide. E) Patient 3 right leg prior to stem cell transplant. F) Legs of Patient 3 legs 20 days after transplantation.